DE153121C - - Google Patents
Info
- Publication number
- DE153121C DE153121C DE1902153121D DE153121DA DE153121C DE 153121 C DE153121 C DE 153121C DE 1902153121 D DE1902153121 D DE 1902153121D DE 153121D A DE153121D A DE 153121DA DE 153121 C DE153121 C DE 153121C
- Authority
- DE
- Germany
- Prior art keywords
- acid
- parts
- water
- alcohol
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 10
- ONSRHZZYERIKNZ-UHFFFAOYSA-N 8-(trichloromethyl)-3,7-dihydropurine-2,6-dione Chemical compound ClC(C1=NC=2NC(NC(C=2N1)=O)=O)(Cl)Cl ONSRHZZYERIKNZ-UHFFFAOYSA-N 0.000 claims description 4
- 150000001735 carboxylic acids Chemical class 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- VRZJGNXBSRQZGM-UHFFFAOYSA-N xanthine-8-carboxylic acid Chemical class N1C(=O)NC(=O)C2=C1N=C(C(=O)O)N2 VRZJGNXBSRQZGM-UHFFFAOYSA-N 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 3
- 150000001447 alkali salts Chemical class 0.000 claims description 3
- 238000007127 saponification reaction Methods 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 claims 1
- 159000000011 group IA salts Chemical class 0.000 claims 1
- 235000019441 ethanol Nutrition 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 4
- LZMQYKYIWVJMIS-UHFFFAOYSA-N 2-(7-methyl-2,6-dioxopurin-3-yl)acetic acid Chemical compound N1C(=O)N(CC(=O)O)C=2N=CN(C)C=2C1=O LZMQYKYIWVJMIS-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000011056 potassium acetate Nutrition 0.000 description 3
- HCYFGRCYSCXKNQ-UHFFFAOYSA-N 2-(1,3-dimethyl-2,6-dioxo-7-purinyl)acetic acid Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CC(O)=O)C=N2 HCYFGRCYSCXKNQ-UHFFFAOYSA-N 0.000 description 2
- MLYBHNJSBBBPNE-UHFFFAOYSA-N 3-methyl-2,6-dioxo-7H-purine-8-carboxylic acid Chemical compound O=C1NC(=O)N(C)C2=C1NC(C(O)=O)=N2 MLYBHNJSBBBPNE-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- ZAFKUFCBXHZEGD-UHFFFAOYSA-N carbonic acid;1,3,7-trimethylpurine-2,6-dione Chemical compound OC(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C ZAFKUFCBXHZEGD-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- -1 xanthincarboxylic acid alkali salt Chemical class 0.000 description 2
- TWNSCSKRVKTOJQ-UHFFFAOYSA-N 1,3,7-trimethyl-8-(trichloromethyl)purine-2,6-dione Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=C(C(Cl)(Cl)Cl)N2C TWNSCSKRVKTOJQ-UHFFFAOYSA-N 0.000 description 1
- LFHHOHMIVKIHMG-UHFFFAOYSA-N 8-methylcaffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=C(C)N2C LFHHOHMIVKIHMG-UHFFFAOYSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- SXBANYCOTBORNU-UHFFFAOYSA-N C(=O)(OC)CN1C(NC(C=2N(C=NC1=2)C)=O)=O Chemical compound C(=O)(OC)CN1C(NC(C=2N(C=NC1=2)C)=O)=O SXBANYCOTBORNU-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FHUWMSATSRLPCA-UHFFFAOYSA-N ClC(Cl)(Cl)CN1C(NC(C=2N(C=NC1=2)C)=O)=O Chemical compound ClC(Cl)(Cl)CN1C(NC(C=2N(C=NC1=2)C)=O)=O FHUWMSATSRLPCA-UHFFFAOYSA-N 0.000 description 1
- VJMZMSNWNFGORW-UHFFFAOYSA-N N1C(=O)N(CC(=O)OCC)C=2N=CN(C)C=2C1=O Chemical compound N1C(=O)N(CC(=O)OCC)C=2N=CN(C)C=2C1=O VJMZMSNWNFGORW-UHFFFAOYSA-N 0.000 description 1
- JNSICMYBDNHKPM-UHFFFAOYSA-N O=C(C1=NC=NC1(N(C1=O)Cl)Cl)N1Cl Chemical class O=C(C1=NC=NC1(N(C1=O)Cl)Cl)N1Cl JNSICMYBDNHKPM-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 description 1
- 229940065721 systemic for obstructive airway disease xanthines Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT19302D AT19302B (it) | 1902-12-01 | 1904-07-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE153121C true DE153121C (it) |
Family
ID=419786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1902153121D Expired - Lifetime DE153121C (it) | 1902-12-01 | 1902-12-01 |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE153121C (it) |
-
1902
- 1902-12-01 DE DE1902153121D patent/DE153121C/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE153120C (it) | ||
| DE668489C (de) | Verfahren zur Darstellung von 2, 4-Dioxo-3, 3-dialkyltetrahydropyridin-6-carbonsaeureestern bzw. der entsprechenden freien Saeuren | |
| DE915809C (de) | Verfahren zur Herstellung von heterocyclischen Sulfonamiden | |
| DE951723C (de) | Verfahren zur Herstellung N-substituierter Normorphin- oder Dihydronormorphinverbindungen bzw. deren Estern und Salzen | |
| DE946804C (de) | Verfahren zur Herstellung von schwefelhaltigen Abkoemmlingen der Barbitursaeure | |
| DE3620215A1 (de) | Benzamide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| DE352980C (de) | Verfahren zur Darstellung von Carbonsaeuren der Purinreihe | |
| DE2008332C3 (de) | 2-Methyl-S-methoxy-3-indolylacetohydroxamsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE351464C (de) | Verfahren zur Darstellung von Derivaten einer hydrierten 2-Phenylchinolin-4-carbonsaeure | |
| DE2143720C3 (de) | Verfahren zur Herstellung von reinem DL-Tryptophan | |
| DE335993C (de) | Verfahren zur Herstellung von Hydantoinen | |
| DE818047C (de) | Verfahren zur Herstellung von konzentrierten neutralen Loesungen des Theophyllins | |
| CH452528A (de) | Verfahren zur Herstellung von neuen Derivaten eines Pyrido-oxazins | |
| DE591677C (de) | Verfahren zur Gewinnung von basischen Estern fettaromatischer Saeuren | |
| DE656741C (de) | Verfahren zur Darstellung von Lysergsaeurehydrazid | |
| DE557814C (de) | Verfahren zur Darstellung von N-substituierten zwei- oder mehrkernigen Aminooxyverbindungen | |
| DE648001C (de) | Verfahren zur Darstellung am Kohlenstoff und am Stickstoff substituierter Barbitursaeuren | |
| AT160494B (de) | Verfahren zur Darstellung von Thiazoliumverbindungen. | |
| AT203004B (de) | Verfahren zur Herstellung von neuen Estern des Piperidyl-(2)-phenylcarbinols und von deren Salzen | |
| DE867592C (de) | Verfahren zur Herstellung von neutralen oder nahezu neutralen Loesungen substituierter Xanthine | |
| DE1445426C (de) | Verfahren zur Herstellnng von Den vaten der 2 Thiobarbitursaure | |
| DE1620172C (de) | Optisch aktives oder racemisches 2,3-Dimethoxy-10-aminoberbin, dessen Salze und Verfahren zur Herstellung dieser Verbindung | |
| AT36131B (de) | Verfahren zur Herstellung von azylierten Oxyaminosäureestern. | |
| DE429100C (de) | Verfahren zur Darstellung eines jodsubstituierten Oxindols | |
| DE605916C (de) | Verfahren zur Darstellung von Verbindungen des 1-Phenyl-2, 3-dimethyl-4-isopropyl-5-pyrazolons |